In myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), TP53 mutation and TP53 loss is associated with clonal evolution, complex karyotypes and a very poor prognosis [1, 2]. This evidence concerns the gene TP53 and acute myeloid leukemia.